Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort (2021)
Attributed to:
KCL Application for a Mental Health Data Pathfinder award
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.09.03.21263023
Publication URI: http://dx.doi.org/10.1101/2021.09.03.21263023
Type: Preprint